Pomalidomide Formyl Impurity - Request Quote
Pomalidomide Formyl Impurity
| SZ CAT No: | SZ-P055029 |
| CAS No | NA |
| Mol.F. | C14H11N3O5 |
| Mol.Wt. | 301.3 |
| Inv. Status | Synthesis on demand |
Chemical Name :
Shipping Temperature :
HSN Code :
Country of Origin :
Smiles :
Usage Note:
Pomalidomide Formyl Impurity is chemically N-(2-(2,6-dioxopiperidin-3-yl)-1,3-dioxoisoindolin-4-yl)formamide. Pomalidomide Formyl Impurity is supplied with detailed characterization data compliant with regulatory guideline. Pomalidomide Formyl Impurity can be used for the analytical method development, method validation (AMV), Quality Controlled (QC) application for Abbreviated New Drug Application (ANDA) or during commercial production of Pomalidomide.
The product can be used as reference standards and further traceability against pharmacopeial standards (USP or EP) can be provided based on feasibility. SynZeal products are for analytical purpose only and not for human use.
Applications & Regulatory Use Cases
buy high quality Pomalidomide Formyl Impurity
Purchase Pomalidomide Formyl Impurity
Pomalidomide Formyl Impurity suppliers
Pomalidomide Formyl Impurity manufacturers
Pomalidomide Formyl Impurity price
Order Pomalidomide Formyl Impurity
Enquire Pomalidomide Formyl Impurity
Pomalidomide Formyl Impurity cost
Pomalidomide Formyl Impurity Supplier
Pomalidomide Formyl Impurity Distributor
Pomalidomide Formyl Impurity for Method Validation
Pomalidomide Reference Standard
Pomalidomide Formyl Impurity for ANDA Filing
Pomalidomide Formyl Impurity for Forced Degradation Studies
Pomalidomide Formyl Impurity Identification Standards
Pomalidomide Formyl Impurity for DMF Filing
Related Products
Disclaimer
SynZeal product information given on this website is as per the existing understanding while publishing the details on website. The customer is responsible for assessing the accuracy of the information at the time of actual purchase.
SynZeal will update these details as per new developments or findings in product specifications without further notice.